Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Martin
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patient age \> 18 years,
primary kidney transplantation;
at least 12 months after kidney transplantation;
immunosuppression: calcineurin inhibitors, mycophenolic acid analogues and corticosteroids;
living donor or donation after brain death (DBD) donor;
patient cooperation;
regular check-ups in Transplant-Nephrology surgery at University Hospital Martin;
provision of a sample of the first-morning urine;
signed informed consent.
patient age \> 18 years,
chronic kidney injury or acute kidney injury
performed renal biopsy
patient cooperation;
regular check-ups in Transplant-Nephrology surgery at University Hospital Martin;
provision of a sample of the first-morning urine;
signed informed consent.
You may not be if
• patient age \< 18 years;
* secondary/tertiary kidney transplantation;
* kidney transplantation in the last 12 months;
* absence of ≥1 of the basic immunosuppressants (calcineurin inhibitors, mycophenolic acid analogues and corticosteroids);
* contaminated sample of the first-morning urine (for example, menstruation);
* non-provision of a sample of the first-morning urine;
* disagreement of the patient with the Examination and inclusion in the study.
patient age \< 18 years;
absence of renal biopsy or non-represenantative sample of renal biopsy
contaminated sample of the first-morning urine (for example, menstruation);
non-provision of a sample of the first-morning urine;
disagreement of the patient with the Examination and inclusion in the study.
Clareo Health | Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).
